Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2782-2785
doi: 10.1161/CIRCULATIONAHA.107.749655
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shanahan, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shanahan, C. M.
Related Collections
Right arrow Pathophysiology

(Circulation. 2007;116:2782-2785.)
© 2007 American Heart Association, Inc.


Editorial

Inflammation Ushers in Calcification

A Cycle of Damage and Protection?

Catherine M. Shanahan, PhD

From the Division of Cardiovascular Medicine, Kings College London, London, United Kingdom.

Correspondence to Catherine M. Shanahan, PhD, Cardiovascular Division, James Black Centre, Kings College London, 125 Coldharbour Ln, London SE5 9NU, UK. E-mail cathy.shanahan@kcl.ac.uk


Key Words: Editorials • atherosclerosis • calcium • imaging • inflammation


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The layman’s term "hardening of the arteries" is synonymous with vascular disease and describes the ubiquitous calcification of the intima and media of the vessel wall that occurs in atherosclerosis and aging. Vascular calcification measured and quantified by electron beam computer tomography is a powerful predictor of myocardial infarction, vascular complications such as amputation, and all-cause mortality.1 Despite this fact, calcification has remained a neglected pathology, particularly in the field of atherosclerosis. This neglect is due in part to the controversy surrounding whether calcification is a bystander marker of disease load or acts to induce plaque rupture and thus increase the cardiovascular event rate; it is also due to the long-held belief that vascular calcification is an end-stage dystrophic process and therefore not amenable to manipulation. However, huge progress has been made over the last 10 years in elucidating the cell biological mechanisms underlying vascular calcification.

Article p 2841

Consensus now exists that calcification is a regulated process, orchestrated by vascular smooth muscle cells (VSMCs) and occurring stepwise in a manner analogous to physiological mineralization processes. In the normal vessel wall, VSMCs are protected from calcification by local and circulating proteins such as matrix Gla protein and fetuin-A that act as mineralization inhibitors. However, in response to insults, VSMCs may die by apoptosis and release apoptotic bodies or may be induced by signals and mechanisms that are still not well defined to release matrix vesicles.2 These small membrane-bound microparticles have the capacity to concentrate calcium and phosphate to allow crystal . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Covic, P. Kothawala, M. Bernal, S. Robbins, A. Chalian, and D. Goldsmith
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1506 - 1523.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
L. Masi, A. Gozzini, A. Franchi, D. Campanacci, A. Amedei, A. Falchetti, F. Franceschelli, G. Marcucci, A. Tanini, R. Capanna, et al.
A Novel Recessive Mutation of Fibroblast Growth Factor-23 in Tumoral Calcinosis
J. Bone Joint Surg. Am., May 1, 2009; 91(5): 1190 - 1198.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Aikawa, M. Aikawa, P. Libby, J.-L. Figueiredo, G. Rusanescu, Y. Iwamoto, D. Fukuda, R. H. Kohler, G.-P. Shi, F. A. Jaffer, et al.
Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease
Circulation, April 7, 2009; 119(13): 1785 - 1794.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. J. Duer, T. Friscic, D. Proudfoot, D. G. Reid, M. Schoppet, C. M. Shanahan, J. N. Skepper, and E. R. Wise
Mineral Surface in Calcified Plaque Is Like That of Bone: Further Evidence for Regulated Mineralization
Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 2030 - 2034.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Towler
Oxidation, Inflammation, and Aortic Valve Calcification: Peroxide Paves an Osteogenic Path
J. Am. Coll. Cardiol., September 2, 2008; 52(10): 851 - 854.
[Full Text] [PDF]


Home page
IBMS BoneKEyHome page
D. A. Towler
Vascular Calcification: A Perspective On An Imminent Disease Epidemic
IBMS BoneKEy, February 1, 2008; 5(2): 41 - 58.
[Abstract] [Full Text] [PDF]